To assess whether ASK1 may contribute to the development of hepatic steatosis and NASH in humans, we analyzed ASK1 mRNA expression in the liver of lean and obese subjects with or without type 2 diabetes. The gene discussed is MAP3K5; the disease is fatty liver disease.